Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Market Cap

Jazz Pharmaceuticals has a market cap or net worth of $10.16 billion as of February 2, 2026. Its market cap has increased by 36.39% in one year.

• Market Cap: 10.16B
• Enterprise Value: 13.61B
• 1-Year Change: 36.39%
• Ranking: #935
• Category: Mid-Cap
• Stock Price: $167.20

Market Cap Chart

Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $10.16B, an increase of 2,234.42%. That is a compound annual growth rate of 18.37%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	10.00B	-3.24%
Dec 31, 2025	10.33B	38.75%
Dec 31, 2024	7.45B	-3.86%
Dec 29, 2023	7.74B	-22.80%
Dec 30, 2022	10.03B	28.09%
Dec 31, 2021	7.83B	-14.84%
Dec 31, 2020	9.20B	8.89%
Dec 31, 2019	8.45B	12.94%
Dec 31, 2018	7.48B	-7.37%
Dec 29, 2017	8.07B	23.62%
Dec 30, 2016	6.53B	-24.46%
Dec 31, 2015	8.64B	-12.72%
Dec 31, 2014	9.90B	35.42%
Dec 31, 2013	7.31B	137.27%
Dec 31, 2012	3.08B	89.28%
Dec 30, 2011	1.63B	112.63%
Dec 31, 2010	765.90M	213.64%
Dec 31, 2009	244.20M	340.00%
Dec 31, 2008	55.50M	-84.62%
Dec 31, 2007	360.90M	-17.09%
Jun 1, 2007	435.30M	-

View and export this data all the way back to 2007. Sign Up Today.

Related Stocks

Company	Market Cap
Summit Therapeutics	11.17B
Exelixis	11.13B
Madrigal Pharmaceuticals	11.11B
Avidity Biosciences	10.93B
BioMarin Pharmaceutical	10.86B
Bio-Techne	9.99B
Arrowhead Pharmaceuticals	9.71B
Axsome Therapeutics	9.29B